Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis.
<h4>Background</h4>Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC) tumor marker that can be used to assess patient prognosis. Since the value of DCP in predicting the prognosis of hepatocellular carcinoma patients treated with transarterial chemotherapy remains...
Main Authors: | Ming Yang, Xuejun Zhang, Jinlong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0225170 |
Similar Items
-
Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
by: Lee Yong Kang, et al.
Published: (2013-01-01) -
Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
by: Rong Zhu, et al.
Published: (2014-01-01) -
DIAGNOSTIC ROLE OF SERUM DES-γ-CARBOXY PROTHROMBIN AND GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
by: Po-Heng Chuang, et al.
Published: (2007) -
Changes in alpha-fetoprotein and des-γ-carboxy-prothrombin after transarterial chemoembolization and their value in predicting treatment outcome
by: YAN Lele
Published: (2019-01-01) -
Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis.
by: Shuangshuang Li, et al.
Published: (2020-01-01)